Presumed Familial Late-Onset Medullary Thyroid Cancer in a patient with a germline
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Background:
Medullary thyroid carcinoma (MTC) accounts for 15%
of thyroid cancers. It arises in the C-cells of the
thyroid, and is often metastatic at presentation.
Approximately 75% of MTC cases are sporadic.
Heritable MTC is subdivided into three categories:
MEN2A, familial medullary thyroid carcinoma (FMTC),
and MEN2B. Determination of the particular mutation
may guide the timing of prophylactic total
thyroidectomy in family members who carry the
mutation.

Case presentation:
A 54-year-old woman presented for unintentional
weight loss. Her primary care physician detected a
thyroid lesion on physical examination. Neck
ultrasound showed a right 1.4 cm nodule with
microcalcifications, a 1.4 cm extrathyroidal mass,
and other hypoechoic nodules. FNA revealed
medullary thyroid cancer. Preoperative CT scans of
the chest, abdomen, and pelvis were negative.
Preoperative calcitonin and CEA were elevated at
1743 pg/mL and 64.3 ng/mL respectively. Plasma
free metanephrines, PTH, and calcium were normal.
TSH was 5.81 mIU/L. There was no family history of
MEN, adrenal disease, thyroid cancer, or calcium
disorders.

Microscopy:
Figure 1

Figure 2a

Figure 2b

Figure 3

Fig. 1—Follicular and acinar
architecture (H&E stain, 10x)
Fig. 2a and 2b—Papillary
architecture with amyloid
deposition (H&E stain, 20x)
Fig. 3—Plasmacytoid cells
with finely granular, “salt and
pepper” chromatin (H&E
stain, 40x)

Microscopic examination shows a neoplasm with solid, follicular, acinar (Fig.
1) and papillary (Fig. 2) architecture with multiple foci of amyloid deposition.
High power view shows a uniform cell population with plasmacytoid features
and finely granular, “salt and pepper” chromatin (Fig. 3).

She underwent total thyroidectomy with bilateral LN
dissection. The right laryngeal nerve was encased in tumor.
Pathology showed multifocal MTC with bilateral involved
lymph nodes, the largest of which was 1.5 cm. Perineural
and angiolymphatic invasion was seen. Ten days
postoperatively, calcitonin was 176 pg/mL. Seven months
postoperatively, calcitonin was 146 pg/mL and CEA was 6.2
ng/mL.
Genetic testing was positive for a germline point mutation in
nucleotide c. 2304 in RET proto-oncogene codon 768, with
a G>C change at exon 13 causing glutamic acid to change to
aspartic acid. This mutation can be associated with MEN2A
or with FMTC. The patient's 21-year-old son tested positive
for the same mutation and her 30-year-old son did not.

Multiple sources advise patients with FMTC with
germline codon 768 mutation and no clinical
manifestations to undergo prophylactic total
thyroidectomy by age 5-10. The exact timing remains
controversial. Patients require genetic counseling prior
to surgery. It was recommended therefore that the
patient’s relatives with the mutation receive testing for
pheochromocytoma and genetic counseling to discuss
the timing of prophylactic total thyroidectomy. Two
sisters tested positive for the mutation; her other 8
other siblings did not. The syndrome is presumed to be
FMTC based upon available clinical and laboratory
data.

Conclusion:
The primary recommended therapy for MTC is total
thyroidectomy. In patients with FMTC, the specific
mutation may guide the timing of prophylactic total
thyroidectomy in family members without clinically
obvious disease who test positive for the mutation.
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